Vivani Medical, Inc.
VANI
$1.33
-$0.01-0.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.34M | 2.16M | 2.11M | 2.17M | 2.50M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.56M | 6.46M | 6.31M | 5.68M | 6.23M |
| Operating Income | -6.56M | -6.46M | -6.31M | -5.68M | -6.23M |
| Income Before Tax | -6.30M | -6.05M | -6.04M | -5.36M | -6.04M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.30M | -6.05M | -6.04M | -5.36M | -6.04M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.30M | -6.05M | -6.04M | -5.36M | -6.04M |
| EBIT | -6.56M | -6.46M | -6.31M | -5.68M | -6.23M |
| EBITDA | -6.46M | -6.37M | -6.20M | -5.58M | -6.13M |
| EPS Basic | -0.11 | -0.11 | -0.11 | -0.10 | -0.12 |
| Normalized Basic EPS | -0.07 | -0.07 | -0.07 | -0.06 | -0.07 |
| EPS Diluted | -0.11 | -0.11 | -0.11 | -0.10 | -0.12 |
| Normalized Diluted EPS | -0.07 | -0.07 | -0.07 | -0.06 | -0.07 |
| Average Basic Shares Outstanding | 59.24M | 57.42M | 55.25M | 55.02M | 52.20M |
| Average Diluted Shares Outstanding | 59.24M | 57.42M | 55.25M | 55.02M | 52.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |